Advertisement

Topics

NuProbe Company Profile

08:49 EDT 22nd July 2018 | BioPortfolio


News Articles [5 Associated News Articles listed on BioPortfolio]

NuProbe spins off, gets IP from Wyss Institute

Concurrent with an $11mm Series A, NuProbe Inc. spun off from Harvard University’s Wyss Institute and licensed worldwide rights to a DNA nanotechnology-based variant-detecting method.

Series A brings in $11mm for NuProbe

Molecular diagnostics firm NuProbe Inc. raised $11mm in its Series A financing led by Sequoia China and Serica Partners, which were joined by WuXi AppTec Corporate Ventures.

Harvard's Wyss Institute launches NuProbe to facilitate global precision medicine

(Wyss Institute for Biologically Inspired Engineering at Harvard) NuProbe Global will commercialize the Wyss Institute's DNA nanotechnology-based variant-detecting method as a fast, low-cost and multi...

Mass. molecular diagnostics company gets $11M boost

A round of Series A financing pulled in $11 million for Cambridge, Mass.-based NuProbe, an early-stage molecular diagnostics  -More- 

NuProbe Announces $11 Million Series A Funding Round

Molecular diagnostics startup to expand reach of precision medicine NuProbe, an early stage molecular diagnostics company, raised $11 million to continue development of...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "NuProbe" on BioPortfolio

We have published hundreds of NuProbe news stories on BioPortfolio along with dozens of NuProbe Clinical Trials and PubMed Articles about NuProbe for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NuProbe Companies in our database. You can also find out about relevant NuProbe Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record